ANNEE 2019

Publié le 14/02/2020 à 10h53

Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V ; MAPT/DSA study group. Anticholinergic exposure and cognitive decline in older adults : Effect of anticholinergic exposure definitions in a 3-year analysis of the Multidomain Alzheimer Preventive Trial (MAPT) study. Br J Clin Pharmacol. 2019 ;85:71-99.

Andre L, Gallini A, Montastruc F, Montastruc JL, Piau A, Lapeyre-Mestre M, Gardette V. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old : a systematic review. Eur J Clin Pharmacol. 2019 ;75:1631-1644.

Araujo M, Hurault-Delarue C, Bouilhac C, Petiot D, Benevent J, Vayssière C, Vidal S, Montastruc JL, Damase-Michel C, Lacroix I. Non-Steroidal Anti-Inflammatory Drug (NSAID) Prescriptions from the 6th Month of Pregnancy : Impact of Advice from Health Authorities. Fundam Clin Pharmacol. 2019 ;33:581-588.

Bagheri H. Interest of pharmacoepidemiology for the study of anticoagulants. Therapie. 2019 ;74:245-248.

Bataillard M, Beyens MN, Mounier G, Vergnon-Miszczycha D, Bagheri H, Cathebras P. Muscle Damage Due to Fusidic Acid-Statin Interaction : Review of 75 Cases From the French Pharmacovigilance Database and Literature Reports. Am J Ther. 2019 ;26:e375-e379.

Baudou E, Benevent J, Montastruc JL, Touati G, Hachon Le Camus C. Adverse Effects of Treatment with Valproic Acid during the Neonatal Period. Neuropediatrics. 2019 ;50:31-40.

Bégaud B, Montastruc JL. Pharmacoepidemiology, the new paradigm of drug evaluation. Therapie. 2019 ;74:167-168.

Benevent J, Lacroix I. Medication and pregnancy, asssessing the risk-benefit balance. Actualités pharmaceutiques. 2019 ;588:21-27.

Benevent J, Araujo M, Hurault-Delarue C, Montastruc JL, Sommet A, Lacroix I, Damase-Michel C. Pharmacoepidemiology in pregnancy. Therapie. 2019 ;74:289-300.

Benevent J, Hurault-Delarue C, Araujo M, Montastruc JL, Lacroix I, Damase-Michel C. POMME : The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure. Drug Saf. 2019 ;42:45-54.

Benevent J, Hurault-Delarue C, Araujo M, Montastruc F, Montastruc JL, Lacroix I, Damase-Michel C. Higher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties. Fundam Clin Pharmacol. 2018 ;33:314-326.

Berger E, Delpierre C, Despas F, Bertoli S, Bérard E, Bombarde O, Bories P, Sarry A, Laurent G, Récher C, Lamy S. Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization ? Results from a French longitudinal observational study among older patients. BMC Cancer. 2019 ;19:883.

Carr DF, Francis B, Jorgensen AL, Zhang E, Chinoy H, Heckbert SR, Bis JC, Brody JA, Floyd JS, Psaty BM, Molokhia M, Lapeyre-Mestre M, Conforti A, Alfirevic A, van Staa T, Pirmohamed M. Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink. Clin Pharmacol Ther. 2019 ;106:1353-1361.

Charlton R, Damase-Michel C, Hurault-Delarue C, Gini R, Loane M, Pierini A, Puccini A, Neville A, Snowball J, Morris JK ; EUROmediSAFE consortium. Did advice on the prescription of sodium valproate reduce prescriptions to women ? An observational study in three European countries between 2007 and 2016. Pharmacoepidemiol. Drug Saf. 2019 ;28:1519-1528.

Clapes V, Rousseau R, Despas F, Montastruc JL, Olivier P. Adverse Drug Reactions Involving Protein Kinase Inhibitors : A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer. Pharmaceutical Medicine. 2018 ;33:21-27.

Compaci G, Conte C, Oberic L, Ysebaert L, Laurent G, Despas F. Sustained degradation of quality of life in a subgroup of lymphoma survivors : a two-year prospective survey. BMC Cancer. 2019 ;19:1178.

Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran AA, Toutain PL. Levothyrox® New and Old Formulations : Are they Switchable for Millions of Patients ? Clinical Pharmacokinetics. 2019 ;58:827-833.

Concordet D, Gandia P, Montastruc JL, Bousquet‑Mélou A, Lees P, Ferran AA, Toutain PL. Authors’ Reply to Lechat et al. Levothyrox® New and Old Formulations : Are they Switchable for Millions of Patients ? Clinical Pharmacokinetics. 2019 ;58:13553-1354.

Concordet D, Gandia P, Montastruc JL, Bousquet‑Mélou A, Lees P, Ferran AA, Toutain PL. Authors’ Reply to Nicolas. Levothyrox® New and Old Formulations : Are they Switchable for Millions of Patients ? Clinical Pharmacokinetics. 2019 ;58:961-963.

Concordet D, Gandia P, Montastruc JL, Bousquet‑Mélou A, Lees P, Ferran AA, Toutain PL. Authors’ Reply to Castello‑Bridoux et al. Comment on Levothyrox® New and Old Formulations : Are they Switchable for Millions of Patients ? Clinical Pharmacokinetics. 2019 ;58:973-975.

Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran AA, Toutain PL. Authors’ Reply to Coste et al. “Levothyrox® New and Old Formulations : Are they Switchable for Millions of Patients ?” Clinical Pharmacokinetics. 2019 ;58:967-968.

Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran AA, Toutain PL. Author’s Reply to Trechot. Comment on Levothyrox® New and Old Formulations : Are they Switchable for Millions of Patients ? Clinical Pharmacokinetics. 2019 ;58:979-980.

Conte C, Vaysse C, Bosco P, Noize P, Fourrier-Reglat A, Despas F, Lapeyre-Mestre M. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology. Therapie. 2019 ;74:279-288.

Conte C, Bourrel R, Despas F, Lapeyre-Mestre M. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas ? A cohort study based on the French health insurance database in the Midi-Pyrénées region. Fundam Clin Pharmacol. 2019 ;33:327-338.

Crickx E, Poullot E, Moulis G, Goulabchand R, Fieschi C, Galicier L, Meignin V, Coppo P, Delarue R, Casasnovas O, Roos-Weil D, de Leval L, Parrens M, Michel M, Dupuis J, Le Bras F, Fataccioli V, Martin-Garcia N, Godeau B, Haïoun C, Gaulard P, Mahévas M. Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma. Eur J Haematol. 2019 ;103:35-42.

Dardonville Q, Salguiero E, Rousseau V, Chebane L, Faillie JL, Gautier S, Montastruc JL, Carvajal A, Bagheri H. Drug-induced osteoporosis/osteomalacia : analysis in the French and Spanish pharmacovigilance databases. Eur J Clin Pharmacol. 2019 ;75:1705-1711.

De Barros S, Vayr F, Despas F, Strumia M, Podevin C, Gauthier M, Delabesse E, Soulat JM, Laurent G, Huguet F, Herin F. The impact of chronic myeloid leukemia on employment : the French prospective study. Ann Hematol. 2019 ;98:615-623.

De Germay S, Rueter M, Montastruc F, Rousseau V, Lapeyre-Mestre M, Montastruc JL. Trends of atropinic (anticholinergic) exposure in the elderly : a 10-year analysis in the French EGB database. Fundam Clin Pharmacol. 2019 ;33:471-478.

Despas F, Rousseau V, Lafaurie M, De Canecaude C, Durrieu G, Bagheri H, Montastruc F, Montastruc JL. Are lipid-lowering drugs associated with a risk of cataract ? A pharmacovigilance study. Fundam Clin Pharmacol. 2019:33 ;695-702.

Durrieu G, Dardonville Q, Clanet M, Montastruc JL. Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab. Fundam Clin Pharmacol. 2019 ;33:125-126.

Favrelière S, Lafay-Chebassier C, Fauconneau B, Quillet A, Yéléhé-Okouma M, Montastruc F, Pérault-Pochat MC. Illogical association nalmefene and opioids : Analysis in the French pharmacovigilance database.Therapie. 2019 ;79:365-374.

Floyd JS, Bloch KM, Brody JA, Maroteau C, Siddiqui MK, Gregory R, Carr DF, Molokhia M, Liu X, Bis JC, Ahmed A, Liu X, Hallberg P, Yue QY, Magnusson PKE, Brisson D, Wiggins KL, Morrison AC, Khoury E, McKeigue P, Stricker BH, Lapeyre-Mestre M, Heckbert SR, Gallagher AM, Chinoy H, Gibbs RA, Bondon-Guitton E, Tracy R, Boerwinkle E, Gaudet D, Conforti A, van Staa T, Sitlani CM, Rice KM, Maitland-van der Zee AH, Wadelius M, Morris AP, Pirmohamed M, Palmer CAN, Psaty BM, Alfirevic A ; PREDICTION-ADR Consortium and EUDRAGENE. Pharmacogenomics of statin-related myopathy : Meta-analysis of rare variants from whole-exome sequencing. PLoS One. 2019 ;14:e0218115.

Humbert X, Fedrizzi S, Chrétien B, Sassier M, Bagheri H, Combret S, Drici MD, Le Bas F, Puddu PE, Alexandre J. Hypertension induced by serotonin reuptake inhibitors : Analysis of two pharmacovigilance databases. Fundam Clin Pharmacol. 2019 ;33:296-302.

Hurault-Delarue C, Morris JK, Charlton R, Gini R, Loane M, Pierini A, Puccini A, Neville A, Snowball J, Damase-Michel C ; EUROmediSAFE consortium. Prescription of antiepileptic medicines including valproate in pregnant women : A study in three European countries. Pharmacoepidemiol Drug Saf. 2019 ;28:1510-1518.

Hurault-Delarue C, Lacroix I, Bénard-Laribière A, Montastruc JL, Pariente A, Damase-Michel C. Antidepressants during pregnancy : a French drug utilisation study in EFEMERIS cohort. Eur Arch Psychiatry Clin Neurosci. 2019 ;841-849.

Kaguelidou F, Durrieu G, Clavenna A. Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics. Therapie. 2019 ;74:315-324.

Koffi KG, Silué DA, Laurent C, Boidy K, Koui S, Compaci G, Adeba ZH, Kamara I, Botty RP, Bognini AS, Sanogo I, Despas F, Laurent G. AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast : a prospective randomized study. BMC Cancer. 2019 ;19:1247.

Lacroix C, Kheloufi F, Montastruc F, Bennis Y, Pizzoglio V, Micallef J. Serious central nervous system side effects of cephalosporins : A national analysis of serious reports registered in the French Pharmacovigilance Database. J Neurol Sci. 2019 ;398:196-201.

Lafaurie M, Montastruc F. Interest of a pharmacovigilance medical consultation : Example of metformin-induced-vitamin B12 deficiency. Presse Med. 2019 ;48:1216-1221.

Lapeyre-Mestre M, Montastruc F. Interest of pharmacoepidemiology for pharmacodynamics and analysis of the mechanism of action of drugs. Thérapie. 2019 ;74:209-2014.

Mines ML, Pacheco T, Castel-Lacana E, de Boissezon X, Marque P, Montastruc F. Venous thrombosis after botulinum therapy in lower limb : A case report and literature review. Ann Phys Rehabil Med. 2019 ;62:457-458.

Montastruc F, Nie R, Loo S, Rej S, Dell’Aniello S, Micallef J, Suissa S, Renoux C. Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide. JAMA Psychiatry. 2019 ;76:409-417.

Montastruc F, Benevent J, Rousseau V, Durrieu G, Sommet A, Montastruc JL. Risk of Diabetes with Fibrates and Statins : a pharmacoepidemiological study in Vigibase®. Fundam Clin Pharmacol. 2018 ;33:108-112.

Montastruc F, Renoux C, Dell’Aniello S, Simon TA, Azoulay L, Hudson M, Suissa S. Abatacept initiation in rheumatoid arthritis and the risk of cancer : a population-based comparative cohort study. Rheumatology (Oxford). 2019 ;48:1053-1058.

Montastruc F, Khosrow-Khavar F, Sommet A, Renoux C, Montastruc JL. Tamoxifen administration and the risk of Parkinsonism. Eur J Clin Pharmacol. 2019 ;75:135-136.

Montastruc JL, Benevent J, Montastruc F, Bagheri H, Despas F, Lapeyre-Mestre M, Sommet A. What is pharmacoepidemiology ? Definition, methods, interest and clinical applications. Therapie. 2019 ;74:169-174.

Montastruc Jl, Montastruc F, Benevent J, Durrieu G, du Plantier JM, Bagheri H, Sommet A, Damase-Michel C. Tintin in the land of drugs : a pharmacological, pharmacovigilance approach. Therapie. 2019 ; 74:445-447.

Mouly S, Roustit M, Bagheri H, Perault-Pochat MC, Molimard M, Bordet R. The French Levothyrox® crisis : We did the best we could but…. Therapie. 2019 ;74:431-435.

Nguyen KD, Nguyen HA, Vu DH, Le TT, Nguyen HA Jr, Dang BV, Nguyen TN, Nguyen DH, Nguyen TB, Montastruc JL, Bagheri H. Drug-Induced Anaphylaxis in a Vietnamese Pharmacovigilance Database : Trends and Specific Signals from a Disproportionality Analysis. Drug Saf. 2018 ;42:671-682.

Nguyen KD, Tran TN, Nguyen MT, Nguyen HA, Nguyen HA Jr, Vu DH, Nguyen VD, Bagheri H. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database : A subgroup approach to disproportionality analysis. J Clin Pharm Ther. 2019 ;44:69-77.

Nicol C, Moulis F, Bondon-Guitton E, Durrieu G, Montastruc JL, Bagheri H. Does spontaneous adverse drug reactions’ reporting differ between different reporters ? A study in Toulouse Pharmacovigilance Centre. Therapie. 2019 ;5:521-525.

Petitpain N, Devos D, Bagheri H, Rocher F, Gouraud A, Masmoudi K, Coquerel A. Is TNF inhibitor exposure a risk factor foramyotrophic lateral sclerosis ? Fundam Clin Pharmacol. 2019 ;33:689-694.

Peyro-Saint-Paul L, Besnier P, Demessine L, Biour M, Hillaire-Buys D, de Canecaude C, Fedrizzi S, Parienti JJ. Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids : a case-control study in the French Pharmacovigilance Database. J Antimicrob Chemother. 2019 ;74:3291-3294.

Sabatier P, Amar J, Montastruc F, Rousseau V, Chebane L, Bouhanick B, Montastruc JL. Breast cancer and spironolactone : an observational postmarketing study. Eur J Clin Pharmacol. 2019 ;75:1593-98.

Sommet A. Interest of pharmacoepidemiology for the study of antibiotic drugs. Therapie. 2019 ;74:249-253.

Sommet A, Pariente A. Methods in pharmacoepidemiology. Therapie. 2019 ;74:187-197.

Sommet A, Bénévent J, Rousseau V, Chebane L, Douros A, Montastruc JL, Montastruc F. What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm ? A Case/Non-case Study in VigiBase®. J Gen Intern Med. 2019 ;34:502-503.

Tournier M, Montastruc F. Interest of pharmacoepidemiology for the study of psychotropic drugs. Therapie. 2019 ;74:239-244.

Tranchard F, Gauthier J, Hein C, Lacombe J, Brett K, Villars H, Sallerin B, Montastruc JL, Despas F. Drug identification by the patient : Perception of patients, physicians and pharmacists.Therapie. 2019 ;74:591-598.

Truffert E, Fournier Charrière E, Treluyer JM, Blanchet C, Cohen R, Gardini B, Haas H, Liard F, Montastruc JL, Nicollas R, Pondaven S, Stahl JP, Wood C, Couloigner V. Guidelines of the French Society of Otorhinolaryngology (SFORL) : Nonsteroidal anti-inflammatory drugs (NSAIDs) and pediatric ENT infections. Short version. Eur Ann Otorhinolaryngol Head Neck Dis. 2019 ;136:289-294.

Watson S, Durrieu G. Midostaurin, photosensitivity reaction. WHO U M C, 2019:1-7.

Ysebaert L, Larcher M, Compaci G, Oberic L, Sahnes L, Banos A, Araujo C, Sommet A, Laurent G, Despas F. Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy : results of the randomized FORTIS study in chronic lymphocytic leukemia. Ann Hematol. 2019 ;98:931-939.